Determining the global health impact of improved diagnostic technologies for the developing world: supplement to Nature Publishing Group
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
London
Nature Publ. Group
2006
|
| Schriftenreihe: | Nature
444 : Supplement |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Einzelaufnahme eines Zs.-Heftes |
| Beschreibung: | 79 S. Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV022193945 | ||
| 003 | DE-604 | ||
| 005 | 20071107 | ||
| 007 | t | ||
| 008 | 061214s2006 ad|| |||| 00||| eng d | ||
| 035 | |a (OCoLC)634528767 | ||
| 035 | |a (DE-599)BVBBV022193945 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-703 |a DE-706 | ||
| 084 | |a XF 1103 |0 (DE-625)152687:12909 |2 rvk | ||
| 245 | 1 | 0 | |a Determining the global health impact of improved diagnostic technologies for the developing world |b supplement to Nature Publishing Group |
| 264 | 1 | |a London |b Nature Publ. Group |c 2006 | |
| 300 | |a 79 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Nature |v 444 : Supplement | |
| 500 | |a Einzelaufnahme eines Zs.-Heftes | ||
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015405471&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-015405471 | ||
Datensatz im Suchindex
| _version_ | 1804136167951564800 |
|---|---|
| adam_text | CONTENTS
FOREWORD
01 Global health diagnostics
Deborah C. Hay Burgess (Bill Melinda Gates Foundation, USA) et al.
An essential component of evaluating and improving global health is access to
appropriate diagnostic tools. Through this series of papers we hope to further
the dissemination of current knowledge on global health diagnostic needs for the
conditions that most severely affect those living in the developing world.
PAPERS
03 Developing and interpreting models to improve diagnostics in
developing countries
Federico Girosi (RAND Corporation, USA) et al.
Developing a strategy for investment in diagnostic technologies requires an
understanding of the need for, and the health impact of, potential new tools, as well as
the necessary performance characteristics and user requirements. In this paper, we
outline an approach for modelling the health benefits of new diagnostic tools.
09 Reducing the global burden of acute lower respiratory infections in
children: the contribution of new diagnostics
Yee WeiLim (RAND Corporation, USA) etal.
Acute lower respiratory infections (ALRIs) are the primary killer of children in
developing countries. Many children with ALRIs are not properly diagnosed, and
overuse of antibiotics has led to increasing drug resistance. The introduction of simple
and widely accessible diagnostic tests could significantly reduce deaths among children
with ALRIs and reduce the inappropriate use of antibiotics.
19 Reducing the burden of HIV/AIDS in infants: the contribution of
improved diagnostics
Julia E. Aledort (RAND Corporation, USA) et al.
The development of an inexpensive, simple and widely accessible test for diagnosing
human immunodeficiency virus (HIV) infection in infants could significantly reduce
paediatric acquired immunodeficiency syndrome (AIDS) deaths in sub Saharan
Africa.
29 Reducing stunting among children: the potential contribution of
diagnostics
Karen A. Ricci (RAND Corporation, USA) et al.
Stunting affects 147 million children in developing countries. Studies have pointed
to a relationship between stunting and different pathogens that are associated with
diarrhoeal illness. New easy to use tools for diagnosing these pathogens could help to
identify children at risk for growth shortfall, and reduce the prevalence of stunting and
the large burden of disease associated with it.
39 Reducing the burden of childhood malaria in Africa: the role of
improved diagnostics
Maria E. Rafael (RAND Corporation, USA) etal.
Malaria kills 1 million children aged 5 years in sub Saharan Africa annually.
Current control efforts are hampered by increasing drug resistance, unreliable
diagnostics, widespread overtreatment and rising drug costs. In this environment, new
and widely available malaria diagnostics have the potential to save lives and drastically
reduce overtreatment.
49 Reducing the global burden of tuberculosis: the contribution of
improved diagnostics
EmmettKeeler (RANDCorporation, USA) etal.
We estimated the impact of hypothetical new diagnostic tests for tuberculosis (TB) in
patients with persistent cough in developing countries. We found that a variety of new
tests could help better identify TB cases and target treatment, thereby reducing the
burden of disease.
59 Reducing the burden of sexually transmitted infections in resource
limited settings: the role of improved diagnostics
Julia E. Aledort(RAND Corporation, USA) etal.
There is a great need for improved diagnosis of curable bacterial sexually transmitted
infections among women in developing countries. We found that wider access to new
diagnostic tests has a greater overall impact on health outcomes than improvements in
test sensitivity or specificity.
73 Requirements for high impact diagnostics in the developing world
Mickey Urdea (HalteresAssociates, USA) etal.
This paper focuses on the technologies required to meet the global health diagnostics
needs presented in the previous papers, highlighting how new diagnostic technologies
might have the potential to change medical and public health scenarios in the
developing world.
|
| adam_txt |
CONTENTS
FOREWORD
01 Global health diagnostics
Deborah C. Hay Burgess (Bill Melinda Gates Foundation, USA) et al.
An essential component of evaluating and improving global health is access to
appropriate diagnostic tools. Through this series of papers we hope to further
the dissemination of current knowledge on global health diagnostic needs for the
conditions that most severely affect those living in the developing world.
PAPERS
03 Developing and interpreting models to improve diagnostics in
developing countries
Federico Girosi (RAND Corporation, USA) et al.
Developing a strategy for investment in diagnostic technologies requires an
understanding of the need for, and the health impact of, potential new tools, as well as
the necessary performance characteristics and user requirements. In this paper, we
outline an approach for modelling the health benefits of new diagnostic tools.
09 Reducing the global burden of acute lower respiratory infections in
children: the contribution of new diagnostics
Yee WeiLim (RAND Corporation, USA) etal.
Acute lower respiratory infections (ALRIs) are the primary killer of children in
developing countries. Many children with ALRIs are not properly diagnosed, and
overuse of antibiotics has led to increasing drug resistance. The introduction of simple
and widely accessible diagnostic tests could significantly reduce deaths among children
with ALRIs and reduce the inappropriate use of antibiotics.
19 Reducing the burden of HIV/AIDS in infants: the contribution of
improved diagnostics
Julia E. Aledort (RAND Corporation, USA) et al.
The development of an inexpensive, simple and widely accessible test for diagnosing
human immunodeficiency virus (HIV) infection in infants could significantly reduce
paediatric acquired immunodeficiency syndrome (AIDS) deaths in sub Saharan
Africa.
29 Reducing stunting among children: the potential contribution of
diagnostics
Karen A. Ricci (RAND Corporation, USA) et al.
Stunting affects 147 million children in developing countries. Studies have pointed
to a relationship between stunting and different pathogens that are associated with
diarrhoeal illness. New easy to use tools for diagnosing these pathogens could help to
identify children at risk for growth shortfall, and reduce the prevalence of stunting and
the large burden of disease associated with it.
39 Reducing the burden of childhood malaria in Africa: the role of
improved diagnostics
Maria E. Rafael (RAND Corporation, USA) etal.
Malaria kills 1 million children aged 5 years in sub Saharan Africa annually.
Current control efforts are hampered by increasing drug resistance, unreliable
diagnostics, widespread overtreatment and rising drug costs. In this environment, new
and widely available malaria diagnostics have the potential to save lives and drastically
reduce overtreatment.
49 Reducing the global burden of tuberculosis: the contribution of
improved diagnostics
EmmettKeeler (RANDCorporation, USA) etal.
We estimated the impact of hypothetical new diagnostic tests for tuberculosis (TB) in
patients with persistent cough in developing countries. We found that a variety of new
tests could help better identify TB cases and target treatment, thereby reducing the
burden of disease.
59 Reducing the burden of sexually transmitted infections in resource
limited settings: the role of improved diagnostics
Julia E. Aledort(RAND Corporation, USA) etal.
There is a great need for improved diagnosis of curable bacterial sexually transmitted
infections among women in developing countries. We found that wider access to new
diagnostic tests has a greater overall impact on health outcomes than improvements in
test sensitivity or specificity.
73 Requirements for high impact diagnostics in the developing world
Mickey Urdea (HalteresAssociates, USA) etal.
This paper focuses on the technologies required to meet the global health diagnostics
needs presented in the previous papers, highlighting how new diagnostic technologies
might have the potential to change medical and public health scenarios in the
developing world. |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| building | Verbundindex |
| bvnumber | BV022193945 |
| classification_rvk | XF 1103 |
| ctrlnum | (OCoLC)634528767 (DE-599)BVBBV022193945 |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01097nam a2200277 cb4500</leader><controlfield tag="001">BV022193945</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20071107 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">061214s2006 ad|| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)634528767</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV022193945</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield><subfield code="a">DE-706</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XF 1103</subfield><subfield code="0">(DE-625)152687:12909</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Determining the global health impact of improved diagnostic technologies for the developing world</subfield><subfield code="b">supplement to Nature Publishing Group</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London</subfield><subfield code="b">Nature Publ. Group</subfield><subfield code="c">2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">79 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Nature</subfield><subfield code="v">444 : Supplement</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Einzelaufnahme eines Zs.-Heftes</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015405471&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-015405471</subfield></datafield></record></collection> |
| id | DE-604.BV022193945 |
| illustrated | Illustrated |
| index_date | 2024-07-02T16:22:17Z |
| indexdate | 2024-07-09T20:52:06Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-015405471 |
| oclc_num | 634528767 |
| open_access_boolean | |
| owner | DE-703 DE-706 |
| owner_facet | DE-703 DE-706 |
| physical | 79 S. Ill., graph. Darst. |
| publishDate | 2006 |
| publishDateSearch | 2006 |
| publishDateSort | 2006 |
| publisher | Nature Publ. Group |
| record_format | marc |
| series2 | Nature |
| spelling | Determining the global health impact of improved diagnostic technologies for the developing world supplement to Nature Publishing Group London Nature Publ. Group 2006 79 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Nature 444 : Supplement Einzelaufnahme eines Zs.-Heftes HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015405471&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Determining the global health impact of improved diagnostic technologies for the developing world supplement to Nature Publishing Group |
| title | Determining the global health impact of improved diagnostic technologies for the developing world supplement to Nature Publishing Group |
| title_auth | Determining the global health impact of improved diagnostic technologies for the developing world supplement to Nature Publishing Group |
| title_exact_search | Determining the global health impact of improved diagnostic technologies for the developing world supplement to Nature Publishing Group |
| title_exact_search_txtP | Determining the global health impact of improved diagnostic technologies for the developing world supplement to Nature Publishing Group |
| title_full | Determining the global health impact of improved diagnostic technologies for the developing world supplement to Nature Publishing Group |
| title_fullStr | Determining the global health impact of improved diagnostic technologies for the developing world supplement to Nature Publishing Group |
| title_full_unstemmed | Determining the global health impact of improved diagnostic technologies for the developing world supplement to Nature Publishing Group |
| title_short | Determining the global health impact of improved diagnostic technologies for the developing world |
| title_sort | determining the global health impact of improved diagnostic technologies for the developing world supplement to nature publishing group |
| title_sub | supplement to Nature Publishing Group |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015405471&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |